These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31343306)

  • 1. The diagnostic utility of neurophysiologic tests for early diagnostic of transthyretin familial amyloid polyneuropathy.
    Sousa AP; Valdrez K; Cardoso M; Anselmo J; Freitas M; Ferreira H; Coelho T
    Amyloid; 2019; 26(sup1):70. PubMed ID: 31343306
    [No Abstract]   [Full Text] [Related]  

  • 2. Early diagnostic tools in hereditary amyloidosis related to transthyretin (hATTR) V30M autonomic neuropathy.
    de Campos CF; Conceição I; Castro I
    Amyloid; 2019; 26(sup1):35-36. PubMed ID: 31343294
    [No Abstract]   [Full Text] [Related]  

  • 3. TTR-familial amyloid polyneuropathy--neurological aspects.
    Said G; Planté-Bordeneuve V
    Amyloid; 2012 Jun; 19 Suppl 1():25-7. PubMed ID: 22620963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy.
    Lefaucheur JP; Zouari HG; Gorram F; Nordine T; Damy T; Planté-Bordeneuve V
    Clin Neurophysiol; 2018 Aug; 129(8):1565-1569. PubMed ID: 29883834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin familial amyloid polyneuropathy due to lle107Val mutation mimicking atypical chronic inflammatory demyelinating polyneuropathy: case report.
    Gondim FAA; Filha JGH; Jordanova A
    Acta Neurol Belg; 2020 Feb; 120(1):201-203. PubMed ID: 30560419
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
    Ikeda K; Kano O; Ito H; Kawase Y; Iwamoto K; Sato R; Sekine T; Nagata R; Nakamura Y; Hirayama T; Iwasaki Y
    Neurology; 2008 Apr; 70(17):1576; author reply 1576-7. PubMed ID: 18427077
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation between Sudoscan and COMPASS 31: assessment of autonomic dysfunction on hATTR V30M patients.
    Conceição I; de Castro I; Castro J
    Amyloid; 2019; 26(sup1):23. PubMed ID: 31343356
    [No Abstract]   [Full Text] [Related]  

  • 8. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
    Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
    Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myopathic phenotype of familial amyloid polyneuropathy with a rare transthyretin variant: ATTR Ala45Asp.
    Misumi Y; Doki T; Ueda M; Obayashi K; Tasaki M; Tamura A; Ando Y
    Amyloid; 2014 Sep; 21(3):216-7. PubMed ID: 24953234
    [No Abstract]   [Full Text] [Related]  

  • 10. The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.
    Castro J; Miranda B; Castro I; de Carvalho M; Conceição I
    Clin Neurophysiol; 2016 May; 127(5):2222-7. PubMed ID: 27072093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).
    Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Yasuda T; Mukai E; Date Y; Shiomi K; Nakazato M; Katsuno M; Sobue G
    Amyloid; 2019; 26(sup1):24-25. PubMed ID: 31343348
    [No Abstract]   [Full Text] [Related]  

  • 12. [A sporadic case of late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) inborn habitant of Ehime prefecture].
    Harada T; Ishizaki F; Togo M; Yamashita H; Nitta K; Date Y; Nakazato M; Yamamura Y; Nakamura S
    No To Shinkei; 2002 Jul; 54(7):615-9. PubMed ID: 12187722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
    Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH
    Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical variant of familial amyloid polyneuropathy.
    Quan D; Cohen JA
    Muscle Nerve; 2002 Sep; 26(3):417-20. PubMed ID: 12210373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation and management of vitreous and nerve amyloid in familial amyloid polyneuropathy due to variant transthyretin, Phe33Val.
    Gregory ME; Carey M; Hawkins PN; Banerjee S; Gillmore JD
    Br J Ophthalmol; 2008 Jan; 92(1):34-5, 142. PubMed ID: 18156374
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis.
    Masuda T; Ueda M; Misumi Y; Nomura T; Inoue Y; Isoguchi A; Kanenawa K; Tasaki M; Yamashita T; Sonoda Y; Obayashi K; Ando Y
    Amyloid; 2019; 26(sup1):79-80. PubMed ID: 31343297
    [No Abstract]   [Full Text] [Related]  

  • 17. A case report of osteoarthritis associated with hereditary transthyretin amyloidosis ATTRV30M.
    Anan I; Bång J; Lundgren HE; Wixner J; Westermark P
    Amyloid; 2019; 26(sup1):29-30. PubMed ID: 31343355
    [No Abstract]   [Full Text] [Related]  

  • 18. Transthyretin-related familial amyloidotic polyneuropathy.
    Ando Y; Nakamura M; Araki S
    Arch Neurol; 2005 Jul; 62(7):1057-62. PubMed ID: 16009758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misdiagnosis in late versus early onset hATTR amyloidosis patients: experience from a reference centre.
    Falcão de Campos C; Parreira S; Conceição I
    Amyloid; 2019; 26(sup1):37-38. PubMed ID: 31343293
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness of technetium pyrophosphate scintigraphy
    Ruiz-Negrón N; Nativi-Nicolau J; Maurer MS; Moran AE; Kovacsovics T; Bellows BK
    Amyloid; 2019; 26(sup1):71-72. PubMed ID: 31343305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.